Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2004-09-01 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PLATEAU D'HAUTEVILLE (01110), Ain
PHARMACIE DU CRET : revenue, balance sheet and financial ratios
PHARMACIE DU CRET is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PLATEAU D'HAUTEVILLE (01110),
this company of category PME
shows in 2023 a revenue of 3.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CRET (SIREN 479080061)
Indicator
2025
2023
2022
2020
2019
2018
2017
Revenue
N/C
3 119 489 €
2 809 785 €
2 135 088 €
2 160 034 €
2 264 301 €
2 227 998 €
Net income
117 115 €
136 673 €
163 867 €
144 758 €
133 500 €
179 178 €
184 012 €
EBITDA
N/C
180 276 €
204 051 €
179 977 €
163 168 €
245 190 €
264 548 €
Net margin
N/C
4.4%
5.8%
6.8%
6.2%
7.9%
8.3%
Revenue and income statement
In 2025, PHARMACIE DU CRET generates positive net income of 117 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 184 k€ -> 117 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
117 115 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 9%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 82%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
8.875%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
81.775%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2022
2023
2025
Debt ratio
3.044
2.236
1.779
8.689
3.291
2.773
8.875
Financial autonomy
89.504
89.888
89.368
81.616
78.814
77.012
81.775
Repayment capacity
0.29
0.234
0.285
1.169
0.376
0.328
None
Cash flow / Revenue
8.426%
7.541%
5.016%
5.902%
5.061%
4.274%
None%
Sector positioning
Debt ratio
8.882025
2022
2023
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Excellent
In 2025, the debt ratio of PHARMACIE DU CRET (8.88) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
81.78%2025
2022
2023
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Excellent+7 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU CRET (81.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.33 years2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DU CRET (0.33) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 302.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
302.736
Liquidity indicators evolution PHARMACIE DU CRET
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2022
2023
2025
Liquidity ratio
434.78
401.638
347.454
288.502
183.771
159.919
302.736
Interest coverage
0.254
0.749
0.218
1.107
2.863
3.184
None
Sector positioning
Liquidity ratio
302.742025
2022
2023
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Excellent+32 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DU CRET (302.74) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
3.18x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE DU CRET (3.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU CRET
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2022
2023
2025
Operating WCR
281 240 €
324 384 €
309 922 €
372 189 €
168 840 €
163 243 €
0 €
Inventory turnover (days)
30
29
30
30
25
23
0
Customer payment term (days)
4
5
4
5
4
5
0
Supplier payment term (days)
18
23
25
37
27
26
0
Positioning of PHARMACIE DU CRET in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU CRET is estimated at
1 860 385 €
(range 1 262 466€ - 2 919 201€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1262k€1860k€2919k€
1 860 385 €Range: 1 262 466€ - 2 919 201€
NAF 5 année 2025
Valuation method used
Net Income Multiple
117 115 €
×
15.9x
=1 860 386 €
Range: 1 262 467€ - 2 919 201€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CRET with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CRET
What is the revenue of PHARMACIE DU CRET ?
The revenue of PHARMACIE DU CRET in 2023 is 3.1 M€.
Is PHARMACIE DU CRET profitable?
Yes, PHARMACIE DU CRET generated a net profit of 117 k€ in 2025.
Where is the headquarters of PHARMACIE DU CRET ?
The headquarters of PHARMACIE DU CRET is located in PLATEAU D'HAUTEVILLE (01110), in the department Ain.
Where to find the tax return of PHARMACIE DU CRET ?
The tax return of PHARMACIE DU CRET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CRET operate?
PHARMACIE DU CRET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart